IN CASE YOU MISSED IT: Yesterday, STAT News published the below op-ed by Michael Carrier, professor of law at Rutgers Law School and Genevieve Tung, associate director of the Rutgers Law Library. In their op-ed, Carrier, coming off his important testimony last week to the Health Subcommittee of House Committee on Energy & Commerce, and Tung debunk Big Pharma’s disingenuous […]

Continue Reading

WHAT YOU NEED TO KNOW • During a recent Senate Hearing, Big Pharma and its ally, U.S. Senator Chris Coons (D-DE) continued their push for the STRONGER Patents Act, a harmful piece of legislation that would open the open the door for Big Pharma to expand their already out-of-control patent abuse. • During the same […]

Continue Reading

Commends Committee members for exposing Big Pharma’s efforts to abuse the U.S. patent system & deny patient access to more affordable generic medications and life-saving treatments WASHINGTON, D.C. – The Coalition Against Patent Abuse, a diverse coalition of healthcare providers, consumer groups, patient advocacy organizations, free-market advocates and others released the following statement today in response […]

Continue Reading

IN CASE YOU MISSED IT: Yesterday, Morning Consult published the below op-ed by Matthew Lane, executive director of the Coalition Against Patent Abuse. In this must-read piece, Lane praises the ongoing bipartisan efforts of Senators Richard Blumenthal (D-CT) and John Cornyn (R-TX) to rein in Big Pharma’s exploitation of the patent system. However, Lane argues that Congress must […]

Continue Reading

IN CASE YOU MISSED IT: The Washington Examiner published the below op-ed on Friday by Charles Duan, Director of Technology and Innovation Policy at the R Street Institute, examining many ways the STRONGER Patents Act would be disastrous for the patent system, enabling Big Pharma to expand their rampant patent abuse, and for American patients, who will […]

Continue Reading

IN CASE YOU MISSED IT: CNN published the op-ed below today by Lincoln Network co-founder, Garrett Johnson and Innovation Defense Foundation president, Wayne Brough highlighting the importance of inter partes review (IPR) for canceling invalid patents which are a significant cause of the drug pricing crisis facing American patients. This op-ed echoes what CAPA has told lawmakers, that IPR is essential […]

Continue Reading

Coalition organizes letter to Senators Coons and Tillis expressing significant concern that the STRONGER Patents Act would embolden Big Pharma to continue abusing the patent system and continue raising prices on prescription drugs WASHINGTON, D.C. –  Ahead of today’s Senate Judiciary Subcommittee hearing on the STRONGER Patents Act of 2019, over 20 organizations from across […]

Continue Reading

WHAT YOU NEED TO KNOW In case you missed it, Alex Moss with the Electronic Frontier Foundation posted a must-read rebuke of Sen. Coons’ STRONGER Patents Act. Moss’ piece details how this legislation would gut the inter partes review process – an internal process available to the Patent and Trademark Office that saves time and considerable costs […]

Continue Reading